Search

Now showing items 1-10 of 24

The integrin alpha v beta 6: a new target for therapy in non-small cell Lung cancer

Rudran, B; Marshall, JF (2015-01)

A multi-gene signature predicts outcome in patients with pancreatic ductal adenocarcinoma

Haider, S; Wang, J; Nagano, A; Desai, A; Arumugam, P; Dumartin, L; Fitzgibbon, J; Hagemann, T; Marshall, JF; Kocher, HM;... (2014)

Improved usage of the repertoires of pancreatic ductal adenocarcinoma (PDAC) profiles is crucially needed to guide the development of predictive and prognostic tools that could inform the selection of treatment options.

A multi-gene signature predicts outcome in patients with pancreatic ductal adenocarcinoma.

Haider, S; Wang, J; Nagano, A; Desai, A; Arumugam, P; Dumartin, L; Fitzgibbon, J; Hagemann, T; Marshall, JF; Kocher, HM;... (2014)

Targeting of Aberrant alpha v beta 6 Integrin Expression in Solid Tumors Using Chimeric Antigen Receptor-Engineered T Cells

Whilding, LM; Parente-Pereira, AC; Zabinski, T; Davies, DM; Petrovic, RMG; Kao, YV; Saxena, SA; Romain, A; Costa-Guerra, JA; Violette, S;... (2017-01-04)

Integrins as Therapeutic Targets: Successes and Cancers

Raab-Westphal, S; Marshall, JF; Goodman, SL (2017-09)

Investigating in vitro and in vivo alpha v beta 6 integrin receptor-targeting liposomal alendronate for combinatory gamma delta T cell immunotherapy

Hodgins, NO; Al-Jamal, WT; Wang, JT-W; Klippstein, R; Costa, PM; Sosabowski, JK; Marshall, JF; Maher, J; Al-Jamal, KT (2017-06-28)

Pro-migratory and TGF-beta-activating functions of alpha v beta 6 integrin in pancreatic cancer are differentially regulated via an Eps8-dependent GTPase switch

Tod, J; Hanley, CJ; Morgan, MR; Rucka, M; Mellows, T; Lopez, M-A; Kiely, P; Moutasim, KA; Frampton, SJ; Sabnis, D;... (2017-09)

Search

The integrin alpha v beta 6: a new target for therapy in non-small cell Lung cancer

A multi-gene signature predicts outcome in patients with pancreatic ductal adenocarcinoma

A multi-gene signature predicts outcome in patients with pancreatic ductal adenocarcinoma.

Targeting of Aberrant alpha v beta 6 Integrin Expression in Solid Tumors Using Chimeric Antigen Receptor-Engineered T Cells

Integrins as Therapeutic Targets: Successes and Cancers

Investigating in vitro and in vivo alpha v beta 6 integrin receptor-targeting liposomal alendronate for combinatory gamma delta T cell immunotherapy

Targeting CDH17 in Cancer: When Blocking the Ligand Beats Blocking the Receptor?

PHLDA1 Mediates Drug Resistance in Receptor Tyrosine Kinase-Driven Cancer

Therapeutic Targeting of Integrin alpha v beta 6 in Breast Cancer

Pro-migratory and TGF-beta-activating functions of alpha v beta 6 integrin in pancreatic cancer are differentially regulated via an Eps8-dependent GTPase switch

Search

Filters

The integrin alpha v beta 6: a new target for therapy in non-small cell Lung cancer

A multi-gene signature predicts outcome in patients with pancreatic ductal adenocarcinoma

A multi-gene signature predicts outcome in patients with pancreatic ductal adenocarcinoma.

Targeting of Aberrant alpha v beta 6 Integrin Expression in Solid Tumors Using Chimeric Antigen Receptor-Engineered T Cells

Integrins as Therapeutic Targets: Successes and Cancers

Investigating in vitro and in vivo alpha v beta 6 integrin receptor-targeting liposomal alendronate for combinatory gamma delta T cell immunotherapy

Targeting CDH17 in Cancer: When Blocking the Ligand Beats Blocking the Receptor?

PHLDA1 Mediates Drug Resistance in Receptor Tyrosine Kinase-Driven Cancer

Therapeutic Targeting of Integrin alpha v beta 6 in Breast Cancer

Pro-migratory and TGF-beta-activating functions of alpha v beta 6 integrin in pancreatic cancer are differentially regulated via an Eps8-dependent GTPase switch